When Fertilization Is Not Enough: Maternal-Zygotic Transition as a Determinant of Embryo Competence in IVF

A significant concern with IVF is that many embryos fail to develop despite proper fertilization. This gap indicates that factors outside sperm-oocyte fusion influence developmental competency. The maternal-zygotic transition (MZT) is a crucial developmental phase during which control shifts from maternally inherited transcripts to activation of the embryonic genome. During the early stages following fertilization, the embryo depends only on maternal mRNA and proteins amassed throughout oogenesis. For successful development, these transcripts must be expeditiously removed with the concurrent genome activation. Any disruption, whether due to inadequate maternal mRNA degradation, aberrant translational control, or delayed genome activation, has been associated with premature developmental stoppage and diminished blastocyst formation. Principal regulators, such as BTG4, CPEB1, DAZL, and components of the translational machinery, govern this modification and seem to be affected by the quality of the oocyte and the age of the mother. Increasing evidence suggests that disruption of MZT may account for instances of suboptimal embryo development that conventional assessment techniques cannot elucidate. MZT offers a biological framework for assessing embryo competency beyond simple appearance. If scientists had a deeper understanding of this process, they might identify molecular markers and enhance the selection of embryos in IVF.